An Examination of the Effectiveness of SSRIs with clomipramine on OCD Patients
DOI:
https://doi.org/10.47611/jsr.v13i1.2417Keywords:
OCD, Selective Serotonin Reuptake Inhibitors, Clomipramine, NeurotransmittersAbstract
Most psychiatrists begin pharmacotherapy for Obsessive Compulsive Disorder (OCD) treatment with Selective Serotonin Reuptake Inhibitors (SSRIs) because they tend to lead to fewer side effects than other symptom-alleviating medications such as clomipramine. SSRIs have been shown to produce response rates of up to 60% in patients with OCD (Paxos, 2022). However, this leaves a considerable number of patients in need of other treatments. clomipramine may be used as either a monotherapy or in combination with an SSRI, as evidence has highlighted the positive impact it has on patients with OCD (Andrade, 2013). Previous research shows that clomipramine and SSRIs are roughly equivalent in benefit when taken alone (Mago, 2017). That said, less is known about the combination of these two medicines. This review will examine the literature comparing individuals with OCD medicated by either SSRIs or clomipramine alone, as well as those taking both in tandem in order to see which prescription best augments exposure and response prevention-based treatment. In addition, this review will briefly describe alternate treatments to examine other possible approaches to effective psychopharmacology.
Downloads
Metrics
References or Bibliography
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Andrade, C. (2013). Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks. The Journal of Clinical Psychiatry, 74(12): e1128-e1133, https://doi.org/10.4088/JCP.13f08883
Borders, C., Hsu, F., Sweidan, A.J., Matei, E.S., & Bota, R.G., (2018). Deep brain stimulation for obsessive compulsive disorder: A review of results by anatomical target. Mental Illness Journal, 10(2), 40-44, https://doi.org/10.4081/mi.2018.7900
Cascade, E., Kalali, A.H., & Kennedy, S.H. (2009). Real-World Data on SSRI Antidepressant Side Effects. Psychiatry, 6(2):16-18.
Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Leucht, S., Ruhe, H.G., Turner, E.H., Higgins, J.P., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J.P, & Geddes, J.R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391(10128): 1357-1366, https://doi.org/10.1016/S0140-6736(17)32802-7
Deep Brain Stimulation for Obsessive-Compulsive Disorder. (n.d.). Mount Sinai. https://www.mountsinai.org/care/psychiatry/services/ocd-tics/dbs.
Figueroa, Y., Rosenberg, D.R., Birmaher, B., & Keshavan, M.S. (1998). Combination
treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 8(1), 61-67, https://doi.org/10.1089/cap.1998.8.61
Fitzsimmons, S.M., van der Werf, Y.D., van Campen, A.D., Arns, M., Sack, A.T.,
Hoogendoorn, A.W., & van den Heuvel, O.A., (2022). Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis. Journal of Affective Disorders, 302, 302-312, https://doi.org/10.1016/j.jad.2022.01.048
Fung, R., Elbe, D., & Stewart, E.S. (2021). Retrospective Review of
Fluvoxamine-Clomipramine Combination Therapy in Obsessive-Compulsive Disorder in Children and Adolescents. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 30(3), 150-155.
Gillman, P.K. (2009). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology, 151(6), 737-748, https://doi.org/10.1038/sj.bjp.0707253
Hillhouse, T., & Porter, J. (2015). A brief history of the development of antidepressant
drugs: From monoamines to glutamate. Experimental and Clinical Psychopharmacology, 23(1), 1-21, https://doi.org/10.1037/a0038550
How does TMS Work. (n.d.) UNC School of Medicine. https://www.med.unc.edu/psych/patient-care/interventional-psychiatry/tms/how-tms-works/
Law, C. & Boisseau, C.L. (2019). Exposure and Response Prevention in the Treatment of
Obsessive-Compulsive Disorder: Current Perspectives. Psychological Research and Behavior Management 12, 1167-1174, https://doi.org/10.2147/PRBM.S211117
Mago, R. (2017). Clomipramine versus SSRIs for OCD. Simple and Practical Mental Health. https://simpleandpractical.com/clomipramine-versus-ssris-for-ocd/
Marzbani, H., Marateb, H.R., & Mansourian, M., (2016). Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications. Basic and Clinical Neuroscience, 7(2), 143-158, https://doi.org/10.15412/J.BCN.03070208
Medications for OCD. (n.d.). UF Department of Psychiatry. https://psychiatry.ufl.edu/patient-care-services/ocd-program/medcations-for-ocd/.
National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 2801, Clomipramine. Retrieved November 25, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Clomipramine.
Paxos, C. (2022). Moving beyond first-line treatment options for OCD. Mental Health Clinician, 12(5), 300-308, https://doi.org/10.9740/mhc.2022.10.300
Pereira, V., & Hiroaki-Sato, V. (2018). A brief history of antidepressant drug development:
From tricyclics to beyond ketamine. Acta Neuropsychiatrica, 30(6), 307-322. https://doi.org/10.1017/neu.2017.39.
Rodriguez, C.I., Kegeles, L.S., Flood, P., & Simpson, H.B., (2011). Rapid Resolution of
Obsessions After an Infusion of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder: A Case Report. Journal of Clinical Psychiatry, 72(4), 567-569, https://doi.org/10.4088/JCP.10l06653
Scahill, L., Riddle, M.A., McSwiggin-Hardin, M., Ort, S.I., King, R.A., Goodman, W.K.,
Cicchetti, D. & Leckman, J.F. (1997). Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. Journal of American Academy of Child & Adolescent Psychiatry, 36(6), 844-852.
Silvestro, S. & Varvatsis, C. (2021, May 17). SSRIs: Everything You Need to Know. Ro.
https://ro.co/health-guide/ssris-everything-you-need-to-know/
Sürmeli, T., & Ertem, A. (2011). Obsessive compulsive disorder and the efficacy of
qEEG-guided neurofeedback treatment: a case series. Clinical EEG and Neuroscience, 42(3), 195-201, https://doi.org/10.1177/155005941104200310
Thamby, A., Jaisoory, T.S. (2019). Antipsychotic augmentation in the treatment of
obsessive-compulsive disorder. Indian Journal of Psychiatry, 61(1), 51-57, https://doi.org/10.4103/psychiatry.IndianJPsychiatry_519_18
The Effects of Dopamine and Antipsychotic Drugs on the Body’s Ability to Respond to Insulin.
(2019, March 22). University of Pittsburgh Department of Psychiatry. https://www.psychiatry.pitt.edu/effects-dopamine-and-antipsychotic-drugs-bodys-ability-respond-insulin
Understanding Obsessive-Compulsive and Related Disorders. (n.d.). Stanford Medicine.
https://med.stanford.edu/ocd/about/understanding.html
Varigonda, A.L., Jakubovski, E., & Bloch, M.H. (2016). Systematic Review and Meta-Analysis:
Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 851-859, https://doi.org/10.1016/j.jaac.2016.07.768
Washington, J. (2020, November 3). Unveiling the Brain’s Secrets: The History of Antidepressants. Greenbrook TMS NeuroHealth Centers. https://www.greenbrooktms.com/blog/the-history-of-antidepressants#:~:text=The%20history%20of%20antidepressants%20began,dramatic%20change%20in%20well%2Dbeing
White, T. (2017, August 21). K for OCD The Pros and Cons of Ketamine. Stanford Medicine Magazine. https://stanmed.stanford.edu/carolyn-rodriguez-ketamine-ocd/
Wolmark, M. (2023, July 31). 49 OCD Statistics: How Many People Have OCD? Golden Steps ABA. https://www.goldenstepsaba.com/resources/ocd-statistics#:~:text=As%20mentioned
earlier%2C%20OCD%20affects,some%20point%20in%20their%20lives.
Wrobel, S. (2007). Science, serotonin, and sadness: the biology of antidepressants. The FASEB
Journal, 21, 3404-3417, https://doi.org/10.1096/fj.07-1102ufm-A
Yin, H. (n.d.) What ketamine actually does to the brain. New Frontiers Psychiatric and TMS.
https://www.newfrontierspsychiatry.com/what-ketamine-actually-does-to-the-brain/
Published
How to Cite
Issue
Section
Copyright (c) 2024 Emily Skoutas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
